JP2007504112A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007504112A5 JP2007504112A5 JP2006524340A JP2006524340A JP2007504112A5 JP 2007504112 A5 JP2007504112 A5 JP 2007504112A5 JP 2006524340 A JP2006524340 A JP 2006524340A JP 2006524340 A JP2006524340 A JP 2006524340A JP 2007504112 A5 JP2007504112 A5 JP 2007504112A5
- Authority
- JP
- Japan
- Prior art keywords
- hbsag
- composition
- composition according
- hbv
- fragments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10339927.5 | 2003-08-29 | ||
| DE10339927A DE10339927A1 (de) | 2003-08-29 | 2003-08-29 | Zusammensetzung zur Prophylaxe/Therapie von HBV-Infektionen und HBV-vermittelten Erkrankungen |
| PCT/EP2004/009590 WO2005023297A1 (de) | 2003-08-29 | 2004-08-27 | Zusammensetzung zur prophylaxe/therapie von hbv-infektionen und hbv-vermittelten erkrankungen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007504112A JP2007504112A (ja) | 2007-03-01 |
| JP2007504112A5 true JP2007504112A5 (enExample) | 2010-12-16 |
| JP4740133B2 JP4740133B2 (ja) | 2011-08-03 |
Family
ID=34202216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006524340A Expired - Fee Related JP4740133B2 (ja) | 2003-08-29 | 2004-08-27 | Ｈｂｖ感染症およびｈｂｖ介在性疾患の予防／治療用組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20060233832A1 (enExample) |
| EP (1) | EP1660125B1 (enExample) |
| JP (1) | JP4740133B2 (enExample) |
| KR (2) | KR20120026138A (enExample) |
| CN (1) | CN1874787B (enExample) |
| AU (1) | AU2004269882B2 (enExample) |
| BR (1) | BRPI0414026A (enExample) |
| CA (1) | CA2535734A1 (enExample) |
| DE (1) | DE10339927A1 (enExample) |
| ES (1) | ES2541123T3 (enExample) |
| WO (1) | WO2005023297A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1764369A1 (de) | 2005-09-16 | 2007-03-21 | Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH | Vakzine enthaltend trunkiertes HBV core protein plus Saponin-basierendes Adjuvants |
| KR100836745B1 (ko) * | 2007-01-31 | 2008-06-10 | (주)두비엘 | Ｈｂｖ 백신 및 그의 제조 방법 |
| US8293101B2 (en) | 2009-03-13 | 2012-10-23 | Terrasep, Llc | Methods and apparatus for centrifugal liquid chromatography |
| NZ598000A (en) * | 2009-08-07 | 2013-10-25 | Transgene Sa | Composition for treating hbv infection |
| US10076570B2 (en) | 2009-08-07 | 2018-09-18 | Transgene S.A. | Composition for treating HBV infection |
| US9238679B2 (en) * | 2011-02-11 | 2016-01-19 | The Trustees Of The University Of Pennslyvania | Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same |
| AP2013007110A0 (en) * | 2011-02-12 | 2013-09-30 | Globeimmune Inc | Yeast-based therapeutic for chronic hepatitis B infection |
| JP6042871B2 (ja) | 2011-04-21 | 2016-12-14 | アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | Ｂ型肝炎ウイルス（ｈｂｖ）発現の調節 |
| EP2629096A1 (en) * | 2012-02-20 | 2013-08-21 | Roche Diagniostics GmbH | HBV immunocomplexes for response prediction and therapy monitoring of chronic HBV patients |
| WO2014193122A1 (ko) * | 2013-05-31 | 2014-12-04 | (주)셀트리온 | Ｂ형 간염 바이러스를 중화시킬 수 있는 결합 분자 |
| CA2975660A1 (en) * | 2015-03-16 | 2016-09-22 | Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) | Trispecific binding molecules for treating hbv infection and associated conditions |
| CN113058033B (zh) * | 2019-12-16 | 2024-07-09 | 远大赛威信生命科学(南京)有限公司 | 一种用于预防和治疗乙型肝炎的药物组合物及其用途 |
| EP4471055A1 (en) * | 2022-01-25 | 2024-12-04 | Xiamen University | Epitope peptide and antibody for treating hbv infection and related diseases |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5196194A (en) * | 1979-05-24 | 1993-03-23 | The Regents Of The University Of California | Vaccines containing Hepatitis B S-protein |
| EP0389983A3 (en) * | 1989-03-31 | 1991-01-16 | Abbott Laboratories | Monoclonal antibodies to pres2 and pres1 polypeptides of the hepatitis b viral envelope |
| PT97632A (pt) * | 1990-05-11 | 1992-03-31 | Scripps Clinic Res | Processo de obtencao de polipeptidos relacionados com a proteina do antigenio de superficie do virus da hepatite b e de vacinas que os contem |
| CA2041772A1 (en) * | 1990-05-11 | 1991-11-12 | Larry T. Mimms | Monoclonal antibodies to pres2 and pres1 polypeptide of the hepatitis b viral envelope |
| EP0491077A1 (en) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | A composition used as a therapeutic agent against chronic viral hepatic diseases |
| IL101653A0 (en) * | 1991-04-29 | 1992-12-30 | Merck & Co Inc | Multiple hepatitis b virus surface proteins which form particles |
| EP0533263A3 (en) * | 1991-09-20 | 1994-06-08 | Merck & Co Inc | A multivalent hepatitis b virus vaccine |
| US6133244A (en) * | 1993-10-22 | 2000-10-17 | Institut Pasteur | Method for immunization against hepatitis B |
| ZA973367B (en) * | 1996-04-19 | 1997-11-18 | Innogenetics Nv | Method for typing and detecting HBV. |
| GB9608626D0 (en) * | 1996-04-25 | 1996-07-03 | Univ College Of London | Hepatitis b monoclonal antibodies |
| HK1048492A1 (zh) * | 1999-12-03 | 2003-04-04 | Innogenetics N.V. | 新的hbv序列 |
| JP2001294599A (ja) * | 2000-04-12 | 2001-10-23 | Sekisui Chem Co Ltd | 組み換えｂ型肝炎ウィルス表面抗原 |
| RU2286172C2 (ru) * | 2000-08-17 | 2006-10-27 | Трипеп Аб | Вакцины, содержащие рибавирин, и способы их использования |
| RU2233672C1 (ru) * | 2003-03-31 | 2004-08-10 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | Комбинированная вакцина для иммунопрофилактики вирусного гепатита в и д, столбняка и дифтерии |
| RU2233673C1 (ru) * | 2003-03-31 | 2004-08-10 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | Комбинированная вакцина для иммунопрофилактики коклюша, дифтерии, столбняка и вирусного гепатита в и д |
-
2003
- 2003-08-29 DE DE10339927A patent/DE10339927A1/de not_active Ceased
-
2004
- 2004-08-27 CN CN2004800317444A patent/CN1874787B/zh not_active Expired - Fee Related
- 2004-08-27 EP EP04764564.3A patent/EP1660125B1/de not_active Expired - Lifetime
- 2004-08-27 WO PCT/EP2004/009590 patent/WO2005023297A1/de not_active Ceased
- 2004-08-27 JP JP2006524340A patent/JP4740133B2/ja not_active Expired - Fee Related
- 2004-08-27 KR KR1020127003977A patent/KR20120026138A/ko not_active Ceased
- 2004-08-27 BR BRPI0414026-5A patent/BRPI0414026A/pt not_active IP Right Cessation
- 2004-08-27 CA CA002535734A patent/CA2535734A1/en not_active Abandoned
- 2004-08-27 KR KR1020067004038A patent/KR101250029B1/ko not_active Expired - Fee Related
- 2004-08-27 ES ES04764564.3T patent/ES2541123T3/es not_active Expired - Lifetime
- 2004-08-27 AU AU2004269882A patent/AU2004269882B2/en not_active Ceased
-
2006
- 2006-02-28 US US11/365,210 patent/US20060233832A1/en not_active Abandoned
-
2011
- 2011-07-07 US US13/177,860 patent/US20110263822A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sominskaya et al. | Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes | |
| Michel et al. | Hepatitis B vaccines: protective efficacy and therapeutic potential | |
| Glebe et al. | The molecular virology of hepatitis B virus | |
| Valaydon et al. | The virological aspects of hepatitis B | |
| Blum | Hepatitis B virus: significance of naturally occurring mutants | |
| Sureau et al. | Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens | |
| Ulrich et al. | New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge | |
| Sominskaya et al. | A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice | |
| JP2007504112A5 (enExample) | ||
| Pumpens et al. | The true story and advantages of the famous Hepatitis B virus core particles: Outlook 2016 | |
| Tan et al. | Phage display creates innovative applications to combat hepatitis B virus | |
| Inan et al. | Hepatitis B virus: Biology and life cycle | |
| Wang et al. | Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen | |
| CN1874787B (zh) | 预防/治疗hbv感染和hbv介导疾病的组合物 | |
| Vanlandschoot et al. | LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles | |
| Pantazica et al. | Efficient cellular and humoral immune response and production of virus-neutralizing antibodies by the Hepatitis B Virus S/preS116-42 antigen | |
| Wang et al. | Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice | |
| Niedre‐Otomere et al. | Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre‐S1 antigens induce broadly reactive neutralizing antibodies | |
| Geissler et al. | Intracellular retention of hepatitis B virus surface proteins reduces interleukin-2 augmentation after genetic immunizations | |
| Cheong et al. | Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits | |
| Kniskern et al. | Hepatitis B vaccines: blueprints for vaccines of the future | |
| Mancini-Bourgine et al. | Impact of the immunogen nature on the immune response against the major HBV antigens in an HBsAg and HLA-humanized transgenic mouse model | |
| CN1108306A (zh) | 羧端带有前表面抗原1决定簇的重组乙肝疫苗 | |
| CN110055228B (zh) | 用于乙肝病毒感染的重组巨细胞病毒与应用 | |
| US20220112246A1 (en) | Conformational epitope of hepatitis b surface antigen and antibody binding specifically thereto |